Diana Puente

5.7k total citations
32 papers, 1.2k citations indexed

About

Diana Puente is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Diana Puente has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Physiology. Recurrent topics in Diana Puente's work include Smoking Behavior and Cessation (6 papers), Colorectal Cancer Screening and Detection (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Diana Puente is often cited by papers focused on Smoking Behavior and Cessation (6 papers), Colorectal Cancer Screening and Detection (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Diana Puente collaborates with scholars based in Spain, United States and France. Diana Puente's co-authors include Manolis Kogevinas, Núria Malats, Francisco X. Real, Xosé S. Puente, Carlos López-Otı́n, F. FERNÁNDEZ, Cristiane Murta‐Nascimento, Rivas del Fresno M, Aurelia Bustos and Rafael Valdés‐Mas and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Diana Puente

32 papers receiving 1.2k citations

Peers

Diana Puente
Mitchell I. Edelson United States
Tim Harris United Kingdom
Yee Leung Australia
Alexandra Sullivan United States
Thomas Buekers United States
Emese Zsíros United States
Alison H. Brand Australia
Victoria Murday United Kingdom
Diana Puente
Citations per year, relative to Diana Puente Diana Puente (= 1×) peers Gábor Kovács

Countries citing papers authored by Diana Puente

Since Specialization
Citations

This map shows the geographic impact of Diana Puente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Puente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Puente more than expected).

Fields of papers citing papers by Diana Puente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Puente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Puente. The network helps show where Diana Puente may publish in the future.

Co-authorship network of co-authors of Diana Puente

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Puente. A scholar is included among the top collaborators of Diana Puente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Puente. Diana Puente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López‐Jiménez, Tomás, et al.. (2024). Exploring the association between metabolic syndrome, its components and subsequent cancer incidence: A cohort study in Catalonia. Cancer Medicine. 13(16). e7400–e7400. 4 indexed citations
2.
Puente, Diana, Constanza Jacques‐Aviñó, Lucía A. Carrasco‐Ribelles, et al.. (2024). Characterisation, symptom pattern and symptom clusters from a retrospective cohort of Long COVID patients in primary care in Catalonia. BMC Infectious Diseases. 24(1). 82–82. 9 indexed citations
3.
López‐Jiménez, Tomás, et al.. (2022). Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study. PLoS ONE. 17(3). e0264634–e0264634. 25 indexed citations
4.
Roel, Elena, Andrea Pistillo, Martina Recalde, et al.. (2021). Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population‐based multistate cohort study including 4 618 377 adults in Catalonia, Spain. International Journal of Cancer. 150(5). 782–794. 21 indexed citations
5.
Recalde, Martina, Cyntia B. Manzano-Salgado, Yesika Díaz, et al.. (2019). <p>Validation Of Cancer Diagnoses In Electronic Health Records: Results From The Information System For Research In Primary Care (SIDIAP) In Northeast Spain</p>. Clinical Epidemiology. Volume 11. 1015–1024. 29 indexed citations
6.
Bellido, Fernando, Marta Pineda, Gemma Aiza, et al.. (2015). POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genetics in Medicine. 18(4). 325–332. 175 indexed citations
7.
Bárcena, Clea, Vı́ctor Quesada, Annachiara De Sandre‐Giovannoli, et al.. (2014). Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome. BMC Medical Genetics. 15(1). 51–51. 30 indexed citations
8.
Valdés‐Mas, Rafael, Ana Gutiérrez‐Fernández, Juan Gómez, et al.. (2014). Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy. Nature Communications. 5(1). 5326–5326. 126 indexed citations
9.
Simó, Rafael, Oleguer Plana‐Ripoll, Diana Puente, et al.. (2013). Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study. PLoS ONE. 8(11). e79968–e79968. 22 indexed citations
10.
Puente, Diana, et al.. (2012). A cross-sectional study of the appropriateness of colonoscopy requests in the Spanish region of Catalonia. BMJ Open. 2(6). e002207–e002207. 2 indexed citations
11.
Docampo, Elisa, Marta Ribasès, Mónica Gratacòs, et al.. (2012). Association of Neurexin 3 polymorphisms with smoking behavior. Genes Brain & Behavior. 11(6). 704–711. 25 indexed citations
12.
Puente, Diana, et al.. (2011). The role of gender in a smoking cessation intervention: a cluster randomized clinical trial. BMC Public Health. 11(1). 369–369. 16 indexed citations
13.
Puente, Xosé S., Vı́ctor Quesada, Fernando G. Osorio, et al.. (2011). Exome Sequencing and Functional Analysis Identifies BANF1 Mutation as the Cause of a Hereditary Progeroid Syndrome. The American Journal of Human Genetics. 88(5). 650–656. 154 indexed citations
14.
Cabezas, Carmen, et al.. (2011). Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study). Addiction. 106(9). 1696–1706. 37 indexed citations
15.
Bartolomé-Moreno, Cruz, et al.. (2011). Actitudes de los españoles frente a los espacios libres de humo de tabaco. Atención Primaria. 44(3). 138–144. 5 indexed citations
16.
Puente, Diana, Edurne Zabaleta‐del‐Olmo, Teresa Rodríguez-Blanco, et al.. (2011). Gender differences in sexual risk behaviour among adolescents in Catalonia, Spain. Gaceta Sanitaria. 25(1). 13–19. 29 indexed citations
17.
Cabezas, Carmen, et al.. (2009). Effectiveness of a stepped primary care smoking cessation intervention (ISTAPS study): design of a cluster randomised trial. BMC Public Health. 9(1). 48–48. 19 indexed citations
19.
Malats, Núria, Aurelia Bustos, Cristiane Murta‐Nascimento, et al.. (2005). P53 as a prognostic marker for bladder cancer: a meta-analysis and review. The Lancet Oncology. 6(9). 678–686. 243 indexed citations
20.
Puente, Diana, Núria Malats, Lluís Cecchini, et al.. (2002). Gender-Related Differences in Clinical and Pathological Characteristics and Therapy of Bladder Cancer. European Urology. 43(1). 53–62. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026